Your browser doesn't support javascript.
loading
Favorable outcome of hematopoietic stem cell transplantation in late-onset Krabbe disease.
Mitsutake, Akihiko; Matsukawa, Takashi; Iwata, Atsushi; Ishiura, Hiroyuki; Mitsui, Jun; Mori, Harushi; Toya, Takashi; Honda, Akira; Kurokawa, Mineo; Sakai, Norio; Tsuji, Shoji; Toda, Tatsushi.
Affiliation
  • Mitsutake A; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
  • Matsukawa T; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan. Electronic address: matsukawa1012@gmail.com.
  • Iwata A; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
  • Ishiura H; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan.
  • Mitsui J; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Mori H; Department of Radiology, School of Medicine, Jichi Medical University, Tochigi, Japan.
  • Toya T; Department of Hematology, The University of Tokyo Hospital, Tokyo, Japan; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Honda A; Department of Hematology, The University of Tokyo Hospital, Tokyo, Japan.
  • Kurokawa M; Department of Hematology, The University of Tokyo Hospital, Tokyo, Japan.
  • Sakai N; Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, Japan.
  • Tsuji S; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan; Institute of Medical Genomics, International University of Health and Welfare, Chiba, Japan.
  • Toda T; Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Brain Dev ; 45(7): 408-412, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37080866
ABSTRACT

BACKGROUND:

Late-onset Krabbe disease is a disorder with autosomal recessive inheritance caused by a deficiency in galactocerebrosidase (GALC) activity. Its late-onset form usually shows slow disease progression with atypical symptoms including spastic paresis. The efficacy of hematopoietic stem cell transplantation (HSCT) in late-onset Krabbe disease has not been fully established. CASE REPORT We describe the case of a patient with late-onset Krabbe disease showing progressive spastic paraparesis. At the age of 18, one and a half years after the development of symptoms, the patient underwent HSCT. After HSCT, the patient's GALC activity returned to a normal level and the lesions in the brain and spinal cord became faint on images. Over two and a half years after the HSCT, the patient's gait remained spastic, however, an improvement in gait speed and modified Rankin Scale score was observed. No severe adverse events occurred during this period.

CONCLUSION:

Our experience reported herein provides additional evidence for a favorable course in HSCT conducted in the early course of late-onset Krabbe disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Leukodystrophy, Globoid Cell Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Brain Dev Year: 2023 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Leukodystrophy, Globoid Cell Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Brain Dev Year: 2023 Document type: Article Affiliation country: Japón